HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Engerix B vaccine in prophylaxis of hepatitis B virus infection in children with diabetes].

Abstract
Twenty children with diabetes received Engerix B vaccine against virus hepatitis B. The antibody level was studied one month after completion of accelerated vaccination course. All patients achieved protective antibody level. The number of patients with diabetes in Poland is increasing. Virus hepatitis B makes worse the prognosis. Good effects of vaccinations are the encouragement to undertaking such management in all diabetic clinics in Poland.
AuthorsA Tańska
JournalWiadomosci lekarskie (Warsaw, Poland : 1960) (Wiad Lek) Vol. 47 Issue 3-4 Pg. 107-10 (Feb 1994) ISSN: 0043-5147 [Print] Poland
Vernacular TitleSzczepionka engerix B w zapobieganiu zakazenia wirusem zapalenia watroby typu B (HBV) u dzieci chorych na cukrzyce.
PMID7975633 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Engerix-B
  • Hepatitis B Antibodies
  • Hepatitis B Vaccines
  • Vaccines, Synthetic
Topics
  • Adolescent
  • Child
  • Diabetes Complications
  • Female
  • Hepatitis B (immunology, prevention & control)
  • Hepatitis B Antibodies (analysis)
  • Hepatitis B Vaccines (administration & dosage)
  • Humans
  • Male
  • Poland
  • Vaccines, Synthetic (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: